Jane Street Group, LLC Crispr Therapeutics Ag Call Options Transaction History

Jane Street Group, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$44.62 - $62.75 $2.8 Million - $3.94 Million	62,800 New	62,800 $2.95 Million
Q1 2022 May 17, 2022	BUY	$53.19 - $79.24 $9.56 Million - $14.2 Million	179,700 Added 58.63%	486,200 $30.5 Million
Q4 2021 Feb 15, 2022	BUY	$70.09 - $111.29 $9.48 Million - $15.1 Million	135,300 Added 79.03%	306,500 $23.2 Million
Q3 2021 Nov 16, 2021	SELL	$110.2 - $156.64 $22.8 Million - $32.4 Million	-207,100 Reduced 54.74%	171,200 $19.2 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $4.02 Million - $6.46 Million	-39,900 Reduced 9.54%	378,300 $61.2 Million
Q1 2021 May 18, 2021	BUY	$110.72 - $210.04 $1.26 Million - $2.39 Million	11,400 Added 2.8%	418,200 $51 Million
Q4 2020 Feb 17, 2021	BUY	$79.67 - $173.23 $20.1 Million - $43.6 Million	251,700 Added 162.28%	406,800 $62.3 Million
Q3 2020 Nov 17, 2020	SELL	$78.5 - $100.64 $2.22 Million - $2.85 Million	-28,300 Reduced 15.43%	155,100 $13 Million
Q2 2020 Aug 17, 2020	BUY	$38.5 - $76.05 $6.65 Million - $13.1 Million	172,600 Added 1598.15%	183,400 $13.5 Million
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $235,760 - $437,710	-7,000 Reduced 39.33%	10,800 $458,000
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $194,404 - $387,589	5,300 Added 42.4%	17,800 $1.08 Million
Q2 2018 Aug 15, 2018	BUY	$42.62 - $73.59 $532,750 - $919,875	12,500 New	12,500 $735,000

489

57.9M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.